Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsUpgradesPrice Target
Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $85 price target.
Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $85 price target.